The abstract is read at the publisher; the summary is JClub's.
Fluorescent dyes for detecting protein aggregates are compared by binding mechanisms and performance metrics, linking quantum yield, fluorescence enhancement, and affinity to aggregate recognition across in vitro and in vivo contexts.
- Why it matters: Protein aggregation underlies disorders such as Alzheimer’s disease, Parkinson’s disease, and type 2 diabetes, but reliable detection and characterization of amorphous and amyloid aggregates remains a key barrier to mechanism studies and diagnostics.
- What they did: This review contrasts classical and emerging fluorescent dyes, correlating binding specificity and metrics (quantum yield, fluorescence enhancement, binding affinity) with recognition mechanisms like TICT restriction, π–π stacking, hydrophobic, and electrostatic interactions.
- The result: It categorizes dyes by BBB crossing, PET suitability, environmental sensitivity, nucleic acid binding affinity, LCOs, and nanoparticle conjugation, providing guidance for selecting probes to distinguish amyloid versus amorphous aggregates and informing rational dye design.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.